Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-12-020833
Filing Date
2012-03-26
Accepted
2012-03-23 20:32:00
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a12-1119_710qa.htm 10-Q/A 1535598
2 EX-31.1 a12-1119_7ex31d1.htm EX-31.1 10331
3 EX-31.2 a12-1119_7ex31d2.htm EX-31.2 10349
4 EX-32.1 a12-1119_7ex32d1.htm EX-32.1 8860
  Complete submission text file 0001104659-12-020833.txt   4636789

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alth-20110930.xml EX-101.INS 713052
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alth-20110930.xsd EX-101.SCH 12901
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alth-20110930_cal.xml EX-101.CAL 29988
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alth-20110930_def.xml EX-101.DEF 22178
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT alth-20110930_lab.xml EX-101.LAB 113945
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alth-20110930_pre.xml EX-101.PRE 75487
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020 3034266262
ALLOS THERAPEUTICS INC (Filer) CIK: 0001097264 (see all company filings)

EIN.: 541655029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-29815 | Film No.: 12713037
SIC: 2834 Pharmaceutical Preparations